Market Cap 628.24M
Revenue (ttm) 1.08B
Net Income (ttm) 95.40M
EPS (ttm) N/A
PE Ratio 3.47
Forward PE 3.55
Profit Margin 8.83%
Debt to Equity Ratio -2.15
Volume 838,600
Avg Vol 698,040
Day's Range N/A - N/A
Shares Out 59.21M
Stochastic %K 37%
Beta 1.11
Analysts Sell
Price Target $16.67

Company Profile

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headqu...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 862 401 0000
Address:
300 Kimball Drive, Suite 300, Parsippany, United States
BillionerOfKing
BillionerOfKing Feb. 4 at 12:44 AM
$EMBC Current Stock Price: $10.92 Contracts to trade: $10.0 EMBC Feb 20 2026 Call Entry: $0.80 Exit: $1.12 ROI: 40% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
RunnerSignals
RunnerSignals Jan. 30 at 10:33 PM
Are these stocks screaming "buy" or "bye"? ​$ABT $EXLS $FDS $PTC $EMBC one is showing a massive volume spike! full breakdown here: https://stocksrunner.com/news/2026-01-30-5-oversold-stocks-to-buy
0 · Reply
RunnerSignals
RunnerSignals Jan. 30 at 2:22 PM
The RSI is screaming oversold for these names! $LOGI $DCBO $EMBC $MMYT $NUKK are you catching the dip or waiting? https://stocksrunner.com/news/2026-01-30-oversold-stocks-to-watch
0 · Reply
NVDAMillionaire
NVDAMillionaire Jan. 20 at 7:02 PM
$EMBC Really good write-up that perfectly summarizes EMBC's present situation. So if you want to bring your EMBC knowledge up to date or just discover EMBC, this is required reading. https://everyticker.com/quote/EMBC/analysis/embecta-s-post-spin-pivot-cost-discipline-meets-glp-1-growth-optionality-nasdaq-embc
0 · Reply
NVDAMillionaire
NVDAMillionaire Jan. 20 at 7:57 AM
$EMBC Outstanding article that hits the mark on EMBC's current state. So if you want to refresh your EMBC insights or learn about EMBC from scratch, this is a must read. https://everyticker.com/quote/EMBC/analysis/embecta-s-post-spin-pivot-cost-discipline-meets-glp-1-growth-optionality-nasdaq-embc
0 · Reply
ChloroplastC
ChloroplastC Dec. 25 at 12:13 PM
$EMBC The investment narrative is evolving as the market reassesses what truly compounds over time. Commercial adoption must become steadier to neutralize skepticism around sustainability. If milestones arrive on time, perception can shift faster than fundamentals. This becomes a story about execution quality rather than promises made.
0 · Reply
Alien1980
Alien1980 Dec. 15 at 5:24 PM
$EMBC long above 11.9. 🛸🛸
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 5 at 10:25 AM
$EMBC Share Price: $11.67 Contract Selected: May 15, 2026 $10 Calls Buy Zone: $2.23 – $2.76 Target Zone: $3.79 – $4.64 Potential Upside: 60% ROI Time to Expiration: 160 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Arcides
Arcides Nov. 26 at 6:44 PM
$EMBC wrecked...
0 · Reply
yosiyosi
yosiyosi Nov. 25 at 12:45 PM
$EMBC buy more
0 · Reply
Latest News on EMBC
embecta to Report Fiscal First Quarter Financial Results

Jan 22, 2026, 5:00 PM EST - 12 days ago

embecta to Report Fiscal First Quarter Financial Results


Embecta Corp. (EMBC) Q4 2025 Earnings Call Transcript

Nov 25, 2025, 11:23 AM EST - 2 months ago

Embecta Corp. (EMBC) Q4 2025 Earnings Call Transcript


embecta Announces Quarterly Cash Dividend

Nov 25, 2025, 6:00 AM EST - 2 months ago

embecta Announces Quarterly Cash Dividend


embecta announces changes to Board of Directors

Nov 17, 2025, 5:00 PM EST - 2 months ago

embecta announces changes to Board of Directors


Upgrading Embecta Due To Reorganization And Growth Initiatives

Aug 31, 2025, 6:54 AM EDT - 5 months ago

Upgrading Embecta Due To Reorganization And Growth Initiatives


embecta to Participate in Investor Events

Aug 26, 2025, 5:00 PM EDT - 5 months ago

embecta to Participate in Investor Events


Embecta Corp. (EMBC) Q3 2025 Earnings Call Transcript

Aug 8, 2025, 12:08 PM EDT - 6 months ago

Embecta Corp. (EMBC) Q3 2025 Earnings Call Transcript


embecta to Report Fiscal Third Quarter 2025 Financial Results

Jul 24, 2025, 5:00 PM EDT - 6 months ago

embecta to Report Fiscal Third Quarter 2025 Financial Results


Embecta Corp. (EMBC) Q2 2025 Earnings Call Transcript

May 9, 2025, 1:39 PM EDT - 9 months ago

Embecta Corp. (EMBC) Q2 2025 Earnings Call Transcript


Embecta to host Analyst and Investor Day on May 22, 2025

Apr 28, 2025, 7:30 AM EDT - 10 months ago

Embecta to host Analyst and Investor Day on May 22, 2025


embecta to Report Fiscal Second Quarter 2025 Financial Results

Apr 21, 2025, 5:00 PM EDT - 10 months ago

embecta to Report Fiscal Second Quarter 2025 Financial Results


Embecta Corp. (EMBC) Q1 2025 Earnings Call Transcript

Feb 6, 2025, 1:55 PM EST - 1 year ago

Embecta Corp. (EMBC) Q1 2025 Earnings Call Transcript


embecta to Report Fiscal First Quarter 2025 Financial Results

Jan 23, 2025, 5:00 PM EST - 1 year ago

embecta to Report Fiscal First Quarter 2025 Financial Results


New Initiatives Expected To Make Embecta More Profitable

Dec 4, 2024, 8:30 AM EST - 1 year ago

New Initiatives Expected To Make Embecta More Profitable


Overlooked Stock: EMBC

Nov 27, 2024, 4:38 PM EST - 1 year ago

Overlooked Stock: EMBC


Embecta Corp. (EMBC) Q4 2024 Earnings Call Transcript

Nov 26, 2024, 2:04 PM EST - 1 year ago

Embecta Corp. (EMBC) Q4 2024 Earnings Call Transcript


Embecta Corp. (EMBC) Q3 2024 Earnings Call Transcript

Aug 9, 2024, 10:39 AM EDT - 1 year ago

Embecta Corp. (EMBC) Q3 2024 Earnings Call Transcript


embecta to Report Fiscal Third Quarter 2024 Financial Results

Jul 18, 2024, 5:00 PM EDT - 1 year ago

embecta to Report Fiscal Third Quarter 2024 Financial Results


Embecta (EMBC) CEO on Diabetes Treatment Market

May 17, 2024, 4:30 PM EDT - 1 year ago

Embecta (EMBC) CEO on Diabetes Treatment Market


Embecta Corp. (EMBC) Q2 2024 Earnings Call Transcript

May 11, 2024, 6:48 PM EDT - 1 year ago

Embecta Corp. (EMBC) Q2 2024 Earnings Call Transcript


BillionerOfKing
BillionerOfKing Feb. 4 at 12:44 AM
$EMBC Current Stock Price: $10.92 Contracts to trade: $10.0 EMBC Feb 20 2026 Call Entry: $0.80 Exit: $1.12 ROI: 40% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
RunnerSignals
RunnerSignals Jan. 30 at 10:33 PM
Are these stocks screaming "buy" or "bye"? ​$ABT $EXLS $FDS $PTC $EMBC one is showing a massive volume spike! full breakdown here: https://stocksrunner.com/news/2026-01-30-5-oversold-stocks-to-buy
0 · Reply
RunnerSignals
RunnerSignals Jan. 30 at 2:22 PM
The RSI is screaming oversold for these names! $LOGI $DCBO $EMBC $MMYT $NUKK are you catching the dip or waiting? https://stocksrunner.com/news/2026-01-30-oversold-stocks-to-watch
0 · Reply
NVDAMillionaire
NVDAMillionaire Jan. 20 at 7:02 PM
$EMBC Really good write-up that perfectly summarizes EMBC's present situation. So if you want to bring your EMBC knowledge up to date or just discover EMBC, this is required reading. https://everyticker.com/quote/EMBC/analysis/embecta-s-post-spin-pivot-cost-discipline-meets-glp-1-growth-optionality-nasdaq-embc
0 · Reply
NVDAMillionaire
NVDAMillionaire Jan. 20 at 7:57 AM
$EMBC Outstanding article that hits the mark on EMBC's current state. So if you want to refresh your EMBC insights or learn about EMBC from scratch, this is a must read. https://everyticker.com/quote/EMBC/analysis/embecta-s-post-spin-pivot-cost-discipline-meets-glp-1-growth-optionality-nasdaq-embc
0 · Reply
ChloroplastC
ChloroplastC Dec. 25 at 12:13 PM
$EMBC The investment narrative is evolving as the market reassesses what truly compounds over time. Commercial adoption must become steadier to neutralize skepticism around sustainability. If milestones arrive on time, perception can shift faster than fundamentals. This becomes a story about execution quality rather than promises made.
0 · Reply
Alien1980
Alien1980 Dec. 15 at 5:24 PM
$EMBC long above 11.9. 🛸🛸
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 5 at 10:25 AM
$EMBC Share Price: $11.67 Contract Selected: May 15, 2026 $10 Calls Buy Zone: $2.23 – $2.76 Target Zone: $3.79 – $4.64 Potential Upside: 60% ROI Time to Expiration: 160 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Arcides
Arcides Nov. 26 at 6:44 PM
$EMBC wrecked...
0 · Reply
yosiyosi
yosiyosi Nov. 25 at 12:45 PM
$EMBC buy more
0 · Reply
NJgolfer
NJgolfer Nov. 13 at 3:13 AM
$EMBC hardly followed stock shows a buy signal today.
0 · Reply
NoEmotionzTrade
NoEmotionzTrade Oct. 15 at 1:53 AM
GIPR is one of those rare tickers with built-in value and upside surprise potential. Real property assets, low risk, and whispers of crypto treasury ambitions. If they deliver on that pivot, GIPR could be redefining how real estate + digital assets converge... $FAD $EMBC $ILAG $ARVL $VXRT
0 · Reply
Fugazi_
Fugazi_ Sep. 22 at 2:17 PM
$EMBC Someone is still holding 40k usd worth of call options at 17.5 for next month. I want to see why
0 · Reply
BillStoneberg455
BillStoneberg455 Sep. 21 at 10:54 AM
$EMBC Healthcare technology niche. Thin volume trading. No clear pattern emerging. Avoid.
0 · Reply
G101SPM
G101SPM Sep. 9 at 3:09 PM
G101SPM 8/19/2025, 10:03:19 AM $EMBC 2023 closeout at a loss as random algorithm data. Misplaced data / registered as computer hallucination to a 12.31.23 closeout at a loss.
1 · Reply
JarvisFlow
JarvisFlow Sep. 8 at 10:00 AM
BTIG updates rating for Embecta ( $EMBC ) to Buy, target set at 25.
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 4 at 6:27 PM
$EMBC Great piece that accurately captures EMBC's current position. So if you want to refresh your understanding of EMBC or learn about EMBC for the first time, this is essential reading. https://beyondspx.com/quote/EMBC/embecta-deleveraging-and-strategic-pivot-in-a-competitive-diabetes-market-embc#analysis
0 · Reply
VolumeSpreadAnalysis
VolumeSpreadAnalysis Aug. 23 at 1:23 PM
$EMBC Embecta Corp is facing diabetes device competition and innovation challenges
0 · Reply
IN0V8
IN0V8 Aug. 11 at 2:24 PM
$EMBC Mizuho raises target price to $14 from $12
0 · Reply
OpenOutcrier
OpenOutcrier Aug. 8 at 12:06 PM
$EMBC (+21.0% pre) Embecta Corp. Reports Third Quarter Fiscal 2025 Financial Results https://ooc.bz/l/73208
0 · Reply